Patent application number | Description | Published |
20090317374 | COMPOSITION CONTAINING ARAZYME FOR THE PREVENTION AND TREATMENT OF CANCER - The present invention relates to a pharmaceutical composition for the prevention and treatment of cancer comprising arazyme as an active ingredient. More precisely, when arazyme produced by | 12-24-2009 |
20100278806 | Composition Containing Arazyme for the Prevention and Treatment of Arthritis - Disclosed herein is a composition containing arazyme as an active ingredient for prevention and treatment of arthritis. More specifically, arazyme produced from | 11-04-2010 |
20100291248 | Compositions for Preventing and Treating Obesity, Hyperlipidemia, Atherosclerosis, Fatty Liver, Diabetes or Metabolic Syndrome Containing Extracts of Glycine Max Leaves or Fractions Isolated from the Same as an Active Ingredient - The present invention relates to compositions for preventing and treating obesity, hyperlipidemia, atherosclerosis, fatty liver, diabetes or metabolic syndrome containing extracts of | 11-18-2010 |
20100322917 | PHARMACEUTICAL COMPOSITION CONTAINING ARAZYME FOR THE PREVENTION OF LIVER DYSFUNCTION - The present invention relates to a pharmaceutical composition for the prevention of liver dysfunction which contains arazyme as an active ingredient, more precisely a pharmaceutical composition for the prevention of liver dysfunction which contains arazyme produced by | 12-23-2010 |
20120003204 | COMPOSITION CONTAINING ARAZYME FOR THE PREVENTION AND TREATMENT OF CANDER - The present invention relates to a pharmaceutical composition for the prevention and treatment of cancer comprising arazyme as an active ingredient. More precisely, when arazyme produced by | 01-05-2012 |
20120003205 | PHARMACEUTICAL COMPOSITION CONTAINING ARAZYME FOR THE PREVENTION OF LIVER DYSFUNCTION - The present invention relates to a pharmaceutical composition for the prevention of liver dysfunction which contains arazyme as an active ingredient, more precisely a pharmaceutical composition for treating liver dysfunction which contains arazyme produced by | 01-05-2012 |
20120309074 | NOVEL XYLANASE PRODUCED FROM CELLULOSIMICROBIUM FUNKEI HY-13 - There are provided a novel xylanase and a use of the same. In detail, there are provided a xylanase separated from a | 12-06-2012 |
20130165635 | CLONING AND BASE SEQUENCE DETERMINATION OF NOVEL ITURIN BIOSYNTHESIS GENE FROM ANTAGONISTIC MICROORGANISM BACILLUS SUBTILIS AND CHARACTERISTICS OF THE GENE - The present invention relates to novel iturin biosynthesis genes, and uses thereof. More specifically, the present invention provides novel iturin biosynthesis genes, wherein the iturin biosynthesis genes were cloned from | 06-27-2013 |
20130303602 | NOVEL PTEROCARPAN COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF METABOLIC DISEASE OR COMPLICATION THEREOF, OR FOR ANTIOXIDANT CONTAINING THE SAME AS AN ACTIVE INGREDIENT - The present invention relates to novel pterocarpan compound or pharmaceutically acceptable salt thereof and a composition for the prevention or treatment of metabolic disease or complications thereof comprising the same as an active ingredient. The novel pterocarpan compound of the present invention isolated from soybean leaves inhibits α-glucosidase activity and hACAT activity, and suppresses LDL-oxidation efficiently. Therefore, the compound of the present invention not only can be effectively used for the prevention or treatment of metabolic disease or complications thereof but also can be effectively used as an anti-oxidative composition owing to its excellent anti-oxidative activity. | 11-14-2013 |